eXoZymes, Inc.
General ticker "EXOZ" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $94.2M (TTM average)
eXoZymes, Inc. does not follow the US Stock Market performance with the rate: -21.8%.
Estimated limits based on current volatility of 4.6%: low 6.43$, high 7.05$
Factors to consider:
- Total employees count: 32 (-98.9%) as of 2025
- Top business risk factors: Limited operating history, Operational and conduct risks, Operating losses, Capital raising, Regulatory and compliance
- Current price 12.8% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [7.24$, 17.37$]
- 2026-12-31 to 2027-12-31 estimated range: [6.32$, 15.36$]
Short-term EXOZ quotes
Long-term EXOZ plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $6.01MM |
| Operating Expenses | $1.80MM | $5.93MM | $15.73MM |
| Operating Income | $-1.80MM | $-5.93MM | $-9.72MM |
| Non-Operating Income | $-0.20MM | $0.07MM | $0.45MM |
| R&D Expense | $0.53MM | $1.87MM | $3.71MM |
| Income(Loss) | $-2.00MM | $-5.86MM | $-9.26MM |
| Taxes | $0.04MM | $0.00MM | $-0.11MM |
| Net Income(Loss)* | $-2.04MM | $-5.86MM | $-9.16MM |
| Stockholders Equity | $-0.38MM | $10.42MM | $3.40MM |
| Assets | $3.56MM | $13.03MM | $5.97MM |
| Operating Cash Flow | $-1.18MM | $-8.51MM | $-6.50MM |
| Capital expenditure | $0.29MM | $0.40MM | $0.17MM |
| Investing Cash Flow | $-0.31MM | $-0.36MM | $-0.15MM |
| Financing Cash Flow | $1.00MM | $18.52MM | $-0.03MM |
| Earnings Per Share** | $-0.25 | $-0.72 | $-1.09 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.